Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Prostate specific antigen screening reduces the risk of death from prostate cancer by 13%, one of the largest randomised studies of its kind concludes.1 This overall reduction in mortality was similar ...

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests. Results of the long-term European trial – one of the largest in ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

The UK media is overstating the benefits of prostate specific antigen tests, which can result in risk without benefit, says ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...